Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERISMODEGIB for Pancreatic carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where ERISMODEGIB was used for Pancreatic carcinoma.

Other Indications for ERISMODEGIB

Myelodysplastic syndrome (8) Myelofibrosis (7)

Other Drugs Used for Pancreatic carcinoma

PACLITAXEL (3,386) GEMCITABINE (2,706) IRINOTECAN (2,128) OXALIPLATIN (1,941) CAPECITABINE (1,590) FLUOROURACIL (1,556) GEMCITABINE\GEMCITABINE (1,434) ERLOTINIB (1,089) PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (722) LEUCOVORIN (700)

Related Pages

ERISMODEGIB Full Profile All Pancreatic carcinoma Drugs ERISMODEGIB Demographics ERISMODEGIB Timeline